AC
RGEN icon

AlphaCore Capital’s Repligen RGEN Stock Holding History

AlphaCore Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+2,064
New +$254K 0.01% 949

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AlphaCore Capital's RGEN Position: Q2 2026 in Review

AlphaCore Capital opened a new position in Repligen (RGEN) in Q2 2026: 2,064 shares worth $282K. The stake represents 0.01% of the portfolio and ranks #949 among its holdings.

478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • AlphaCore Capital held 2,064 shares of Repligen worth $282K as of Q2 2026.
  • Repligen was a new AlphaCore Capital position in Q2 2026.
  • Repligen made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #949 holding.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.